State Street SPDR S&P Biotech ETF
XBI
AMEX
Financial Services
Asset Management
$129.44
▼
$2.38
(-1.81%)
Company Details
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Performance
Moderate (34.3%)
↘ Decelerating
1W
▲ 2.54%
1M
▲ 3.70%
3M
▲ 8.48%
6M
▲ 32.62%
YTD
▲ 8.11%
1Y
▲ 80.60%
3Y
▲ 71.06%
1M return (+3.7%) is stronger than 1W (+2.54%) — gains are slowing
Price History
Analyst Price Target
No analyst coverage available
Earnings Estimates
No forward estimates available
No quarterly estimates available
No fundamental snapshot available yet.
{"event":"ticker_viewed","properties":{"ticker":"XBI","listing_kind":"stock","pathname":"/stocks/xbi","exchange":"AMEX","country":"US"}}